AMG:ETR
Amgen
371,80 €
arrow_upward
+1,71%(+6,25) 1d
19 d’ag., 14:10:25 GMT+2 · EUR
search
Tots els símbols
1d
5d
1m
6m
YTD
1a
5a
Màx.
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a AMG...
Obre
366,50 €
Alt
371,85 €
Baix
366,50 €
Capitalització borsària
229,92 kM
Volum mitjà
507,00
Volum
37,00
Alt 52 setmanes
371,85 €
Baix 52 setmanes
230,00 €
Nombre d'empleats
32 k
Obre
366,50 €
Alt
371,85 €
Baix
366,50 €
Capitalització borsària
229,92 kM
Volum mitjà
507,00
Volum
37,00
Alt 52 setmanes
371,85 €
Baix 52 setmanes
230,00 €
Nombre d'empleats
32 k
Notícies
De fonts web i partners de notícies
MarketBeat
·
fa 2 hores
Amgen Inc. $AMGN Shares Purchased by Simplicity Wealth LLC
AD HOC NEWS
·
fa 5 hores
Amgen stock extends 2026 rally as Q2 earnings beat and guidance lifted
TipRanks
·
fa 14 hores
TScan Therapeutics Faces Loss of Key Amgen Partnership
MarketWatch
·
fa 15 hores
Amgen Inc. stock underperforms Tuesday when compared to competitors despite daily gains
Perfil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Sobre Amgen
Conseller delegatRobert A. Bradway
Empleats31,5 k
Fundació8 d’abr. 1980
Seu principalThousand Oaks, Califòrnia, Estats Units d'Amèrica
Sector-
Lloc webamgen.com
El contingut d'IA pot incloure errors. Més informació